Fort Point Capital Partners LLC Bristol Myers Squibb CO Transaction History

Fort Point Capital Partners LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$48.48 - $57.85 $52,261 - $62,362	-1,078 Reduced 15.49%	5,881 $301,000
Q3 2023 Nov 08, 2023	SELL	$57.89 - $64.73 $32,128 - $35,925	-555 Reduced 7.39%	6,959 $403,000
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $66,449 - $73,781	1,043 Added 16.12%	7,514 $480,000
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $7,819 - $8,869	119 Added 1.87%	6,471 $448,000
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $616 - $729	9 Added 0.14%	6,352 $456,000
Q3 2022 Nov 09, 2022	BUY	$0.13 - $76.84 $23 - $13,677	178 Added 2.89%	6,343 $451,000
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $2,033 - $2,239	28 Added 0.46%	6,165 $475,000
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $922 - $1,105	15 Added 0.25%	6,137 $448,000
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $328,322 - $382,747	6,122 New	6,122 $382,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Fort Point Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Fort Point Capital Partners LLC with notifications on news.